SPRID VIDARE I ALLA DINA NÄTVERK
NOTE! Dissemination of material from this website is permitted – indicating the source!
OBS! Spridning av material från denna webbplats är tillåten – med angivande av källan!
MYCKET VIKTIG OCH ALLMÄNBILDANDE ARTIKEL AV DR MERCOLA, LÄS OCH SPRID VIDARE I ALLA DINA NÄTVERK, CITAT
Several COVID-19 Vaccines Are Made Using Aborted Fetal Cells
-
The claim made by some citizen journalists is that certain COVID-19 vaccines “contain cells from an aborted fetus.” One video headline stated: “CONFIRMED — aborted fetus in COVID-19 vaccine”
-
Fact checkers have “debunked” these claims and labeled them false, in one instance because the name of the fetal cell line was incorrect and in others because the vaccines do not literally “contain” these cells; rather, the fetal cell lines were used as a growth medium for the virus during the production phase
-
Fact checkers’ claim that fetal cells are not used in vaccine development because they are clones of the original is perhaps the most ludicrous. There’s no difference between cells growing and multiplying indefinitely in a petri dish and cells growing and multiplying in your body during your lifetime. If the cells in your body are still you, then the cells in the petri dish are still that of the original fetus that was aborted
-
Aside from ethical concerns, some may also object to vaccines manufactured through the use of fetal cell lines on the basis that there may be health risks involved, due to potential DNA contamination. Human fetal cell lines in vaccine production have been linked to both autism and autoimmune diseases
-
Vaccine makers using a fetal cell line in the development of their COVID-19 vaccines include AstraZeneca, Jansen Research and Development/Johnson & Johnson, CanSino Biologics, University of Pittsburgh, ImmunityBio and Altimmune
Slut citat, läs hela artikeln och sprid vidare i alla dina nätverk
This entry was posted on tisdag, december 15th, 2020 at 10:18 and is filed under Okategoriserat. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.